IDEX Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission, reporting third-quarter net sales of $951.7 million and net income attributable to IDEX of $144.1 million.

Key Highlights

  • Net sales: $951.7 million for the three months ended September 30, 2026, compared with $878.7 million for the same period in 2025, according to the filing.
  • Net income attributable to IDEX: $144.1 million for Q3 2026, versus $127.8 million for Q3 2025, as reported in the condensed consolidated statements of income.
  • Basic earnings per share: $1.95 for the three months ended September 30, 2026, up from $1.70 in the prior-year quarter.
  • Nine-month net sales: $2,759.2 million for the nine months ended September 30, 2026, compared with $2,558.4 million for the same period in 2025.
  • Nine-month net income attributable to IDEX: $407.5 million for the nine months ended September 30, 2026, versus $354.9 million for the nine months ended September 30, 2025.
  • Shares outstanding: 73,452,801 shares of common stock outstanding as of October 23, 2026, per the filing's cover page.
  • Restructuring expenses and asset impairments: $3.4 million in Q3 2026, compared with $0.1 million in Q3 2025.

IDEX Corporation's Third-Quarter 2026 Financial Results

IDEX Corporation (NYSE:IEX), a Delaware-incorporated manufacturer headquartered in Northbrook, Illinois, disclosed its unaudited condensed consolidated financial results for the three and nine months ended September 30, 2026 in a Form 10-Q filed October 28, 2026. According to the filing, net sales for the third quarter of 2026 reached $951.7 million, an increase from $878.7 million reported in the third quarter of 2025. Gross profit for Q3 2026 was $429.5 million, compared with $390.6 million in Q3 2025. Operating income for the quarter was reported at $208.0 million, up from $185.8 million in the prior-year period.

The filing reported selling, general and administrative expenses of $218.1 million for Q3 2026, versus $204.7 million in Q3 2025. Restructuring expenses and asset impairments were $3.4 million in the third quarter of 2026, compared with $0.1 million in the same quarter of 2025. Interest expense, net, was $15.4 million for Q3 2026, down from $16.5 million in Q3 2025. Income before income taxes was $192.7 million for Q3 2026, and the provision for income taxes was $48.7 million, resulting in net income of $144.0 million. Net income attributable to IDEX, after accounting for a net loss attributable to noncontrolling interest of $0.1 million, was $144.1 million.

For the nine months ended September 30, 2026, the filing disclosed net sales of $2,759.2 million and operating income of $580.3 million, compared with $2,558.4 million and $515.7 million, respectively, for the nine months ended September 30, 2025. Diluted earnings per common share attributable to IDEX for Q3 2026 and the nine-month period are partially disclosed in the filing, with the basic figure of $1.95 for Q3 2026 and $5.50 for the nine months ended September 30, 2026 stated clearly. The filing also contains forward-looking statements, which the company notes "are subject to inherent uncertainties and risks that could cause actual results to differ materially."

What Was Disclosed

IDEX Corporation's 10-Q for the period ended September 30, 2026 disclosed quarterly net sales of $951.7 million, net income attributable to IDEX of $144.1 million, basic EPS of $1.95, and nine-month net sales of $2,759.2 million, with 73,452,801 shares outstanding as of October 23, 2026.